Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
Shareholders of Hungarian drugmaker Egis, majority-owned by France's Sevier, approved a proposal to pay a HUF 240-per-share dividend on profit from the business year ended September 30 at an annual general meeting on Wednesday. The dividend is double the HUF 120-per-share dividend that Egis has paid for years. CFO Csaba Poroszlai said the dividend was 10% of consolidated net profit. Shareholders approved Egis's Hungarian Accounting Standards P+L statement showing after-tax profit of HUF 20.4 billion on revenue of HUF 131.2 billion.